Expression of beclin 1 in primary salivary adenoid cystic carcinoma and its relation to Bcl-2 and p53 and prognosis

Brazilian Journal of Medical and Biological Research

Volumn 47, Issue 3, 2014, Pages 252-258

  Jiang, L C ^a   Huang, S Y ^a   Zhang, D S ^a   Zhang, S H ^a   Li, W G ^a   Zheng, P H ^a   Chen, Z W ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; Autophagy; Bcl 2; Beclin 1; p53

Indexed keywords

BECLIN 1; PROTEIN BCL 2; PROTEIN P53; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OVERALL SURVIVAL; PERINEURAL INVASION; PROTEIN EXPRESSION; SALIVARY GLAND CARCINOMA; ADOLESCENT; AUTOPHAGY; HEAD AND NECK TUMOR; KAPLAN MEIER METHOD; METABOLISM; PHYSIOLOGY; PROGNOSIS; SALIVARY GLAND TUMOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOMA, ADENOID CYSTIC; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SALIVARY GLAND NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84898868364     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/1414-431X20133231     Document Type: Article

References (37)

1. Gondivkar SM, Gadbail AR, Chole R, Parikh RV. Adenoid cystic carcinoma: a rare clinical entity and literature review. Oral Oncol 2011; 47: 231-236. doi: 10.1016/j.oraloncology. 2011.01.009
2. Dodd RL, Slevin NJ. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006; 42: 759-769. doi: 10.1016/j.oraloncology. 2006.01.001.
3. Lloyd S, Yu JB, Wilson LD, Decker RH. Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 2011; 34: 76-81. doi: 10.1097/ COC.0b013e3181d26d45.
4. Ko YH, Lee MA, Hong YS, Lee KS, Jung CK, Kim YS, et al. Prognostic factors affecting the clinical outcome of adenoid cystic carcinoma of the head and neck. Jpn J Clin Oncol 2007; 37: 805-811. doi: 10.1093/jjco/hym119.
5. Chen N, Debnath J. Autophagy and tumorigenesis. FEBS Lett 2010; 584: 1427-1435. doi: 10.1016/j.febslet.2009.12.034.
6. Mizushima N, Klionsky DJ. Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 2007; 27: 19-40. doi: 10.1146/annurev.nutr.27.061406.093749.
7. Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290: 1717-1721. doi: 10.1126/science.290.5497.1717.
8. Sinha S, Levine B. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008; 27 (Suppl 1): S137-S148. doi: 10.1038/onc.2009.51.
9. Won KY, Kim GY, Kim YW, Song JY, Lim SJ. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum Pathol 2010; 41: 107-112. doi: 10.1016/j.humpath.2009.07.006.
10. Huang X, Bai HM, Chen L, Li B, Lu YC. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci 2010; 17: 1515-1519. doi: 10.1016/j.jocn.2010.03.051.
11. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, et al. Protein andmRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 2007; 30: 429-436.
12. Shen Y, Li DD, Wang LL, Deng R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008; 4: 1067-1068.
13. Dong LW, Hou YJ, Tan YX, Tang L, Pan YF, Wang M, et al. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy 2011; 7: 1222-1229. doi: 10.4161/auto.7.10.16610.
14. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672-676. doi: 10.1038/45257.
15. Furuya N, Yu J, Byfield M, Pattingre S, Levine B. The evolutionarily conserved domain of Beclin 1 is required for Vps34 binding, autophagy and tumor suppressor function. Autophagy 2005; 1: 46-52. doi: 10.4161/auto.1.1.1542.
16. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-939. doi: 10.1016/j.cell.2005.07.002.
17. Levine B, Sinha S, Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008; 4: 600-606.
18. Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Curr Opin Cell Biol 2010; 22: 181-185. doi: 10.1016/j.ceb.2009.12.001.
19. Levine B, Abrams J. p53: The Janus of autophagy? Nat Cell Biol 2008; 10: 637-639. doi: 10.1038/ncb0608-637.
20. Kazakov DV, Grossmann P, Spagnolo DV, Vanecek T, Vazmitel M, Kacerovska D, et al. Expression of p53 and TP53 mutational analysis in malignant neoplasms arising in preexisting spiradenoma, cylindroma, and spiradenocylindroma, sporadic or associated with Brooke-Spiegler syndrome. Am J Dermatopathol 2010; 32: 215-221. doi: 10.1097/DAD.0b013e3181e1d1e8.
21. Szanto PA, Luna MA, Tortoledo ME, White RA. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 1984; 54: 1062-1069. doi: 10.1002/1097-0142 (19840915)54:6,1062::AID-CNCR2820540622.3.0.CO;2-E.
22. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, et al. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009; 5: 303-306. doi: 10.4161/auto.5.3.7491.
23. Huang JJ, Zhu YJ, Lin TY, Jiang WQ, Huang HQ, Li ZM. Beclin 1 expression predicts favorable clinical outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP. Hum Pathol 2011; 42: 1459-1466. doi: 10.1016/ j.humpath.2010.12.014.
24. Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007; 115: 1344-1349. doi: 10.1111/j.1600-0463.2007.00858.x.
25. Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010; 10: 98. doi: 10.1186/1471-2407-10-98.
26. Chen C, Ma Q, Ma X, Liu Z, Liu X. Association of elevated HIF-2alpha levels with low Beclin 1 expression and poor prognosis in patients with chondrosarcoma. Ann Surg Oncol 2011; 18: 2364-2372. doi: 10.1245/s10434-011-1587-5.
27. Miracco C, Cevenini G, Franchi A, Luzi P, Cosci E, Mourmouras V, et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 2010; 41: 503-512. doi: 10.1016/j.humpath.2009.09.004.
28. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42. doi: 10.1016/j.cell.2007.12.018.
29. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007; 21: 1367-1381. doi: 10.1101/gad.1545107.
30. Karantza-Wadsworth V, Patel S, Kravchuk O, Chen G, Mathew R, Jin S, et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev 2007; 21: 1621-1635. doi: 10.1101/gad.1565707.
31. Young AR, Narita M, Ferreira M, Kirschner K, SadaieM, Darot JF, et al. Autophagy mediates the mitotic senescence transition. Genes Dev 2009; 23: 798-803. doi: 10.1101/gad. 519709.
32. Martin SJ. Oncogene-induced autophagy and the Goldilocks principle. Autophagy 2011; 7: 922-923. doi: 10.4161/auto.7.8.15821.
33. Maiuri MC, Criollo A, Kroemer G. Crosstalk between apoptosis and autophagy within the Beclin 1 interactome. EMBO J 2010; 29: 515-516. doi: 10.1038/emboj.2009.377.
34. Camisasca DR, Honorato J, Bernardo V, da Silva LE, da Fonseca EC, de Faria PA, et al. Expression of Bcl-2 family proteins and associated clinicopathologic factors predict survival outcome in patients with oral squamous cell carcinoma. Oral Oncol 2009; 45: 225-233. doi: 10.1016/ j.oraloncology.2008.05.021.
35. Costa AF, Altemani A, Vekony H, Bloemena E, Fresno F, Suarez C, et al. Genetic profile of adenoid cystic carcinomas (ACC) with high-grade transformation versus solid type. Cell Oncol 2011; 34: 369-379. doi: 10.1007/s13402-011-0037-5.
36. Morselli E, Tasdemir E, Maiuri MC, Galluzzi L, Kepp O, Criollo A, et al. Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle 2008; 7: 3056-3061. doi: 10.4161/cc.7.19.6751.
37. Locati LD, Perrone F, Losa M, Mela M, Casieri P, Orsenigo M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol 2009; 45: 986-990. doi: 10.1016/j.oraloncology.2009.05.635.